Subscription contracts make revenue repeat
Multi-year contracts covering hardware, software and service turn most revenue into recurring fees.

An overview of the main reasons to invest and the key risks involved.
Multi-year contracts covering hardware, software and service turn most revenue into recurring fees.
A US government anti-terrorism status reassures cautious buyers and takes years for rivals to obtain.
Visitors walk through without emptying pockets, so venues screen more people with fewer staff.
Any failure to detect a weapon at a screened venue could harm the brand permanently.
An internal investigation, restatement and regulator settlement left legal costs and control weaknesses behind.
Established detection and scanner makers can fund rival products and bundle them cheaply.
Overview of buy and sell case of the business.
Key pieces of information about the business that you need to know about.
The key events that could drive investment opportunities and shift markets.
Customer Additions: The next stretch for Evolv is about how many new venues sign up, how many renew, and whether the newer bag-screening product widens the sale. Each quarter the company reports how many new customers it added, which is the clearest read on whether adoption is broadening beyond its original stadium and school base.
eXpedite Rollout: Evolv's newer bag-screening product, eXpedite, is being deployed alongside its walk-through units. Wider take-up would let the company sell a second system into venues it already serves, lifting the value of each customer relationship without finding a new buyer.
Contract Renewals: Customer contracts typically run around four years, so early cohorts come up for renewal in waves. How many renew, and on what terms, decides whether the recurring revenue base compounds or leaks, and it is the single biggest swing factor in the subscription model.
Profit Crossover: Management has said it aims to expand adjusted profitability margins each year while still growing. Reaching genuine bottom-line profit, rather than profit on an adjusted basis that excludes share-based pay, would remove the question of whether the company needs more outside funding.
Growth Framework To 2031: At its investor day the company set out a multi-year plan targeting roughly 25% average annual revenue growth through 2031. Sustained delivery against that framework would show screening spending is a durable budget line rather than a burst of post-incident buying.
New Markets And Geographies: Evolv has pointed to adoption spreading across different customer types and countries beyond its early stadium and school base. Broader use in hospitals, workplaces, transport and overseas venues would reduce the company's dependence on any single sector or region.
Key pieces of information about the business risks that you need to know about.
Access the most recent investor updates published by the company.
Meet the experienced professionals leading our organization

.png&w=3840&q=75)
Here are the questions that professional investors are asking before making an investment decision.

Evolv Technologies Holdings, Inc.
Evolv sells walk-through weapons detectors that let crowds stream into stadiums, schools and hospitals without emptying pockets or bags, charged as a multi-year subscription rather than a one-off machine sale.

NASDAQ:EVLV
$5.68
978.50m
0
2m
Pricing delayed 15 mins. Aug 19, 2026 5:00 PM